Defence Therapeutics Inc.
Defence Therapeutics Inc.
CSE Index:
Currency:
Defence Therapeutics Inc. is a biotechnology company engaged in the business of research and development, focusing on enhancing delivery of tumor-/ and infectious disease-specific therapeutics. The principal business carried on is the development of a biological drug enhancer platform that improves the efficacy and safety of a multitude of biological/biosimilar-based pharmaceuticals used in the treatment of cancer and infectious diseases.
Defence Therapeutics Inc. (DTC)
SEDAR Information
Company Info
Address
1680, 200 Burrard St.
Vancouver, BC V6C 3L6
CanadaPhone
514-947-2272Email
sebas.plouffe@gmail.comWebsite
https://defencetherapeutics.comListing date
Friday, May 7, 2021Transfer Agent
Computershare Investor Services Inc.Capitalization
Issued & Outstanding:
41,630,174Reserved for Issuance:
7,452,555Company Officers
Sébastien Plouffe, Chief Executive Officer
P. Joseph Meagher, Chief Financial Officer
Bulletins
06/05/2021
2021-0505 – New Listing - Defence Therapeutics Inc. (DTC)
Le 6 mai/May 2021
The common shares of Defence Therapeutics Inc., have been approved for listing on the CSE.
Listing and disclosure documents will be available at www.thecse.com on the trading date.
CSE Filings
Advertisement
Publicité
Upcoming Events
STANY Annual Conference 2023
Monday, March 27, 2023 -7:30am to 8:30pm
